Expression and immunogenicity of recombinant mycobacterium bovis Bacillus Calmette-Guérin strains secreting the antigen ESAT-6 from Mycobacterium tuberculosis in mice

Chinese Medical Journal

Volumn 120, Issue 14, 2007, Pages 1220-1225

  Wang, Li Mei ^a   Shi, Chang Hong ^a   Fan, Xiong Lin ^b   Xue, Ying ^a   Bai, Yin Lai ^a   Xu, Zhi Kai ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Bacillus Calmette Gu rin; ESAT 6; Mycobacterium tuberculosis; Vaccine

Indexed keywords

BCG VACCINE; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; IMMUNOGLOBULIN G; RECOMBINANT VACCINE; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL STRAIN; CAUSE OF DEATH; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; HUMORAL IMMUNITY; IMMUNOGENICITY; MOUSE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN SECRETION; SPLEEN CELL; TUBERCULOSIS;

EID: 34547730199     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200707020-00003     Document Type: Article

References (26)

1. Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994; 271: 698-702.
2. Girard MP, Fruth U, Kieny W. A review of vaccine research and development: tuberculosis. Vaccine 2005; 23: 5725-5731.
3. Ohara N, Yamada T. Recombinant BCG vaccines. Vaccine 2001; 19: 4089-4098.
4. Hanson MS, Lapcevich CV, Haun SL. Progress on development of the live BCG recombinant vaccine vehicle for combined vaccine delivery. Ann N Y Acad Sci 1995; 754: 214-221.
5. Collins DM. New tuberculosis vaccines based on attenuated strains of the Mycobacterium tuberculosis complex. Immunol Cell Biol 2000; 78: 342-348.
6. Mahairas GG, Sabo PJ, Hickey MJ, Singh DC, Stover CK. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol 1996; 178: 1274-1282.
7. Behr MA, Wilson MA, Gill WP, Salamon H, Schoolnik GK, Rane S, et al. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 1999; 284: 1520-1523.
8. Sorensen AL, Nagai S, Houen G, Andersen P, Andersen AB. Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect Immun 1995; 63: 1710-1717.
9. Harboe M, Oettinger I, Wiker HG, Rosenkrands I, Andersen P. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect Immun 1996; 64: 16-22.
10. Andersen P, Andersen AB, Sorensen AL, Nagai S. Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J Immunol 1995; 154: 3359-3372.
11. Pollock JM, Andersen P. Predominant recognition of the ESAT- 6 protein in the first phase of interferon with Mycobacterium bovis in cattle. Infect Immun 1997; 65: 2587-2592.
12. Mustafa AS, Amoudy HA, Wiker HG, Abal AT, Ravn P, Offung F, et al. Comparison of antigen-specific T-cell responses of tuberculosis patients using complex or single antigens of Mycobacterium tuberculosis. Scand J Immunol 1998; 48: 535-543.
13. Ulrichs T, Munk ME, Mollenkopf H, Behr-Perst S, Colangeli R, Gennaro ML, et al. Differential T cell responses to Mycobacterium tuberculosis ESAT6 in tuberculosis patients patients and healthy donors. Eur J Immunol 1998; 28: 3949-3958.
14. Sambrook J, Fritisch EF, Maniatis T. Molecular cloning: a laboratory manual, 2nd ed. New York: Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 1989: 16-66.
15. Parish T, Stoker NG. Mycobacteria Protocols. New Jersey: Humana Press; 1998: 129-145.
16. Shi JH, Zhao YT, Wang JL, Han W, Yan Z, Zhang YQ. Analysis of low molecular peptides by sodium dodecylsulfate-polyacrylamide gel electrophoresis. J Fourth Mil Med Univ (Chin) 2000; 21: 761-763.
17. Andersen P, Askgaard D, Ljungqvist L, Bentzon MW, Heron I. T cell proliferative response to antigens secreted by Mycobacterium tuberculosis. Infect Immun 1991; 59: 1558-1563.
18. Fine PE. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995; 346: 1339-1345.
19. Brandt L, Cunha JF, Olsen AW, Chilima B, Hirsch P, Appelberg R, et al. Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect Immun 2002; 70: 672-678.
20. Dhar N, Rao V, Tyagi AK. Recombinant BCG approach for development of vaccines: cloning and expression of immunodominant antigens of M. tuberculosis. FEMS Microbiol Lett 2000; 190: 309-316.
21. Skjøt RLV, Oettinger T, Rosenkrands I, Ravn P, Brock I, Jacobsen S, et al. Comparative evaluation of Low-Molecular-Mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-Cell antigens. Infect Immun 2000; 68: 214-220.
22. Brandt L, Oettinger T, Holm A, Andersen AB, Andersen P. Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis. J Immunol 1996; 157: 3527-3533.
23. Shi CH, Xu ZK, Zhu DS, Li Y, Bai YL, Xue Y. Screening and construction of recombinant BCG strains expressing the Ag85B-ESAT6 fusion protein. Chin J Tuberc Respir Dis (Chin) 2005; 28: 254-257.
24. Bonecini-Almeida MG, Chitale S, Boutsikakis I, Geng JY, Doo H, He SH, et al. Induction of in vitro human macrophage anti-mycobacterium tuberculosis activity: requirement for IFN-γ and primed lymphocytes. J Immunol 1998; 160: 4490-4498.
25. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993; 178: 2249-2254.
26. Renshaw PS, Panagiotidou P, Whelan A, Gordon SV, Hewinson RG, Williamson RA, et al. Conclusive evidence that the major T-cell antigens of the mycobacterium tuberculosis complex ESAT-6 and CFP-10 form a tight, 1:1 complex and characterization of the structural properties of ESAT-6, CFP-10, and the ESAT-6 CFP-10 complex. Implications for pathogenesis and virulence. J Biol Chem 2002; 277:21598-21603.